← Back to Search

Intervention phase for COVID-19

N/A
Waitlist Available
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Considered a secondary school by the school board
Open for in-person learning during the study period
Timeline
Screening 3 weeks
Treatment Varies
Follow Up over 7 week study period
Awards & highlights

Study Summary

This study is evaluating whether a program that provides take-home saliva testing kits in schools can reduce the spread of SARS-CoV-2 in schools.

Eligible Conditions
  • COVID-19

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~over 7 week study period
This trial's timeline: 3 weeks for screening, Varies for treatment, and over 7 week study period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
SARS-CoV-2 Case Identification
Secondary outcome measures
Impact on secondary transmission
Impact on timing of test for symptomatic individuals
Uptake of take-home saliva kits for testing

Trial Design

2Treatment groups
Active Control
Group I: control phaseActive Control1 Intervention
Schools will start in the control phase (SARS-CoV-2 diagnostic testing at an assessment center, primary care office or acute care center) and transition to the intervention phase at a randomly assigned time point over the course of the study.
Group II: Intervention phaseActive Control1 Intervention
Schools will have take home saliva kits available at the school to support SARS-CoV-2 diagnostic testing. Schools will transition to the intervention phase at a randomly assigned time (wedge) over a 6-week period with all schools receiving the program by the end of the study.

Find a Location

Who is running the clinical trial?

The Hospital for Sick ChildrenLead Sponsor
682 Previous Clinical Trials
6,945,274 Total Patients Enrolled
13 Trials studying COVID-19
20,727 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~17 spots leftby Mar 2025